18269153

Source:http://linkedlifedata.com/resource/pubmed/id/18269153

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002475, umls-concept:C0034951, umls-concept:C0087111, umls-concept:C0395416, umls-concept:C0752094, umls-concept:C1609982
pubmed:issue	1
pubmed:dateCreated	2008-2-13
pubmed:abstractText	To evaluate the efficacy and safety of prophylactic mitomycin C (MMC) during photorefractive keratectomy (PRK) over LASIK flaps for the treatment of residual refractive errors following LASIK.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9505927
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alkylating Agents, http://linkedlifedata.com/resource/pubmed/chemical/Mitomycin
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1081-597X
pubmed:author	pubmed-author:DrakeAntonyA, pubmed-author:HerzigSheldonS, pubmed-author:SrinivasanSathishS
pubmed:issnType	Print
pubmed:volume	24
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	S64-7
pubmed:meshHeading	pubmed-meshheading:18269153-Adult, pubmed-meshheading:18269153-Alkylating Agents, pubmed-meshheading:18269153-Combined Modality Therapy, pubmed-meshheading:18269153-Female, pubmed-meshheading:18269153-Humans, pubmed-meshheading:18269153-Keratomileusis, Laser In Situ, pubmed-meshheading:18269153-Lasers, Excimer, pubmed-meshheading:18269153-Male, pubmed-meshheading:18269153-Middle Aged, pubmed-meshheading:18269153-Mitomycin, pubmed-meshheading:18269153-Myopia, pubmed-meshheading:18269153-Photorefractive Keratectomy, pubmed-meshheading:18269153-Refractive Errors, pubmed-meshheading:18269153-Reoperation, pubmed-meshheading:18269153-Retrospective Studies, pubmed-meshheading:18269153-Surgical Flaps, pubmed-meshheading:18269153-Treatment Outcome, pubmed-meshheading:18269153-Visual Acuity
pubmed:year	2008
pubmed:articleTitle	Photorefractive keratectomy with 0.02% mitomycin C for treatment of residual refractive errors after LASIK.
pubmed:affiliation	Herzig Eye Institute, Toronto, Ontario, Canada. sathish.srinivasan@gmail.com
pubmed:publicationType	Journal Article